Oxfam Report: Eye on the Ball – Medicine regulation, not IP enforcement, can best deliver quality medicines
OXFAM PRESS RELEASE, FEBRUARY 2, 2011: The proliferation of substandard, dangerous medicines in poor countries is being used by rich countries as an excuse to tighten intellectual property rules, boosting the profits of large pharmaceutical companies while making it harder…
